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Background: Acute pancreatitis (AP) is associated with a high death rate in dogs, but accurate
predictors of early death are still lacking.
Objectives: To develop a scoring system for prediction of short-term case fatality in dogs with AP.
Animals: One hundred sixty-nine dogs with AP including 138 dogs in the training cohort and
31 dogs in the validation cohort.
Methods: Multicenter, retrospective cohort study. Survival analysis was used to assess the asso-
ciations with short-term death (within 30 days after admission). Independent predictors of
death were identified by a stepwise selection method and used for the score calculation.
Results: Death rate within 30 days after admission was 33% in the training cohort. Four inde-
pendent risk factors for short-term death were identified in the training cohort: presence of sys-
temic inflammatory response syndrome, coagulation disorders, increased creatinine and ionized
hypocalcemia. Canine Acute Pancreatitis Severity (CAPS) score was developed to predict short-
term death, integrating these 4 factors in a weighted way. A simplified version of CAPS score
(sCAPS) including respiratory rate instead of SIRS was also assessed. The area under the
receiver-operating characteristic curve (AUC) of CAPS and sCAPS scores was 0.92 in the train-
ing cohort with an optimal cutoff of 11 (sensitivity, 89%; specificity, 90%) and 6 (sensitivity,
96%; specificity, 77%), respectively. CAPS and sCAPS score were validated in the validation
cohort with respective AUC of 0.91 and 0.96.
Conclusions and Clinical Importance: We propose 2 scoring systems that allow early and accu-
rate prediction of short-term death in dogs with AP.
KEYWORDS
creatinine, coagulation disorders, hypocalcemia, prognosis, severity, systemic inflammatory
response syndrome
Abbreviations: aHR, adjusted HR; AP, acute pancreatitis; AUC, area under the curve; BIC, Bayesian Information Criteria; CAPS, Canine Acute Pancreatitis Severity;
CI, confidence interval; cPL, canine pancreatic lipase; CRC, C-reactive protein; HR, hazard ratio; NVSA, National Veterinary School of Alfort; NVST, National Veterinary
School of Toulouse; ROC, receiver operating curve; RR, respiratory rate; sCAPS, simplified Canine Acute Pancreatitis Severity; SIRS, systemic inflammatory response
syndrome; Spec cPL, specific canine pancreatic lipase; WBC, white blood cell.
Loïc Desquilbet and Ghita Benchekroun contributed equally to the study.
Received: 12 April 2018 Accepted: 8 January 2019
DOI: 10.1111/jvim.15421
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
© 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
J Vet Intern Med. 2019;33:499–507. wileyonlinelibrary.com/journal/jvim 499
1 | INTRODUCTION
Acute pancreatitis (AP) is common in dogs, but its pathogenesis is not
completely understood.1,2 Mild pancreatitis, which is characterized by
moderate clinical signs (anorexia, abdominal pain, vomiting, and leth-
argy) generally results in full recovery with appropriate medical treat-
ment. In severe pancreatitis, however, acute pancreatic necrosis results
in more severe clinical signs and multisystem complications such as sys-
temic inflammatory response syndrome (SIRS), multiple organ dysfunc-
tion syndrome, or disseminated intravascular coagulation.3,4 In human
medicine, there is an association between the presence of SIRS within
the first 48 hours of severe AP and death.5,6
To date, the diagnosis of AP and the assessment of its severity
remain challenging. Recently developed diagnostic tests have allowed
improvements in the diagnosis of AP. However, the combined sensi-
tivity and specificity of the available tests is still imperfect, and diag-
nosis is usually established on the basis of consistent history, clinical,
laboratory, and ultrasonographic findings.7–11 Currently, there is no
blood test to differentiate mild from severe disease in dogs with
AP.12,13 In human medicine, early identification of severe AP is consid-
ered mandatory to initiate appropriate treatment as early as possible
to decrease death rate.5,14 Several scoring systems including Ranson,
Glasgow, APACHE II (Acute Physiology and Chronic Health Evaluation
II), BISAP (Bedside Index of Severity in Acute Pancreatitis), and
recently the PANC 3 score have been shown to predict the severity
of AP in people.15–19
Despite an increased knowledge about AP, the death rate in dogs
remains high, ranging from 27% to 58%, contrasting with 5% to 15%
death rate reported in human medicine.20–22 Consequently, severity
assessment of AP in dogs appears as a major challenge to implement
adequate treatment and reduce death rate.13,20 Two scoring systems
have been proposed in veterinary medicine to assess the severity of
AP in dogs.12,23 The first was based on the evaluation of organ system
dysfunction.12 In this study, diagnosis of AP was based on high serum
amylase or lipase activity as this study was conducted well before the
routine availability of specific lipase immunoassays or high-resolution
abdominal ultrasonography.7,24 More recently, a clinical severity index
correlated with outcome has been proposed.23 In this study, a signifi-
cant association with outcome was restricted to 4 body systems dys-
function (cardiac and respiratory systems, intestinal integrity, and
vascular force).23 Although informative, this study lacked a multivari-
able analysis. Finally, neither of these 2 scoring systems has been vali-
dated in an independent external cohort of patients.
The aim of this study was to identify independent predictors of
short-term death in dogs with AP, to develop a scoring system to pre-
dict outcome, and, finally, to validate this scoring system in an inde-
pendent external population of dogs with AP.
2 | MATERIALS AND METHODS
2.1 | Case selection
Medical records of dogs presented at the National Veterinary School
of Alfort (NVSA) and the National Veterinary School of Toulouse
(NVST) from January 2008 to December 2015 and diagnosed with AP
were retrospectively reviewed. Dogs from NVSA were used for the
development of a scoring system model (training cohort). The scoring
system was subsequently validated for reliability on an independent
population composed of dogs from NVST (validation cohort).
2.2 | Diagnostic criteria of AP
Diagnosis of AP was based on the following inclusion criteria: acute
onset of at least 2 compatible clinical signs (vomiting, anorexia, abdomi-
nal pain, or lethargy) and specific canine pancreatic lipase (Spec cPL)
concentration >400 μg/L associated or not with ultrasonographic find-
ings consistent with AP (thickened hypoechoic pancreas with blurred
margins, surrounded by hyperechoic adipose tissue) or Spec cPL concen-
tration between 200 and 400 μg/L, abnormal SNAP cPL result (color
intensity of the sample spot equal to or more intense than the control
spot, corresponding to a cPL ≥ 200 μg/L), or both, associated with ultra-
sonographic findings consistent with AP. Dogs were excluded from anal-
ysis if clinical signs were present for more than 7 days or if a previous
episode of AP was reported.
2.3 | Data collection
Data extracted from the electronic medical records included signalment,
history, physical examination findings at admission, CBC, plasma bio-
chemistry profile, electrolytes, coagulation profile, and abdominal ultra-
sonography results obtained at the earliest after admission (within a
maximum delay of 48 hours post-admission). The outcome defined as
death within 30 days of admission (ie, short-term death) was recorded. A
30-day cutoff was selected to appreciate short-term death related to
AP. Dogs dead within 30 days of admission for causes unrelated to AP
or euthanized for financial reasons were right censored at the date of
death. Dogs still alive 30 days of admission were right censored at
the corresponding date (ie, date of admission +30 days). Dogs were
excluded if outcome data were not available. The survival time was
defined as the interval from admission to either the outcome (ie, death
resulting from AP within 30 days of admission) or censoring. Cause and
date of death were obtained in medical records or via telephone contact
with owners. The study protocol was approved by the Ethics Committee
of NVSA. During the study period, informed consents for privacy and
personal data use were not obtained at time of dogs' admission given
that data protection regulation was not applicable. Therefore, an oral
consent was obtained afterwards when telephone contact was needed.
2.4 | Laboratory findings
CBC, biochemistry, and coagulation profile were performed using rou-
tine methods at the diagnostic laboratories of NVSA and NVST. Spec
cPL concentration was measured in a commercial laboratory (Idexx
Laboratories). SNAP cPL test (Idexx Laboratories) was performed in
house according to manufacturer's instruction.
2.5 | Selection of variables
The selection of variables tested as potential risk factors for death in
this study was based on previous data describing complications of AP
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in dogs or on variables already associated with poor prognosis in AP
in dogs.3,4,12,23,25 Eleven binary variables were considered: (1) SIRS
defined by the presence of at least 2 of the following criteria: heart
rate >120 beats per minute, respiratory rate (RR) >20 movements per
minute, body temperature <38.1C or >39.2C, white blood cell
(WBC) count <6000/mm3 or >16 000/mm3;26 (2) coagulation disorders
defined by the presence of at least 1 of the following criteria: throm-
bocytopenia (platelet count <63 000/mm3),27 prothrombin time, acti-
vated partial thromboplastin time prolonged by more than 25% of the
upper end of the reference interval, or both; (3) metabolic acidosis
considered when blood pH < 7.35 and bicarbonate concentration
<15 mEq/L; (4) hepatic injury defined by the presence of increased
alanine aminotransferase (>133 U/L), alkaline phosphatase (>459 U/L)
(ie, >3-fold increase of the upper end of the reference interval), or both;
(5) serum creatinine was considered increased when >1.6 mg/dL;
(6) hyperkalemia (serum potassium >5.3 mEq/L); (7) hyperglycemia
(serum glucose >150 mg/dL); (8) ionized hypocalcemia (ionized cal-
cium <4.4 mg/dL); (9) hypoalbuminemia (serum albumin <2.6 g/dL);
(10) marked elevation of Spec cPL concentrations (>1000 μg/L), and
(11) age (in years).
2.6 | Statistical analysis
Construction of the scoring system was based on a previously
described model.28
The identification of risk factors for short-term death was per-
formed in 2 steps. First, a univariable analysis was performed to iden-
tify potential risk factors, that is, exposures associated with the
outcome with a P-value <.20 (using Kaplan-Meier curves and log-rank
test). Second, for each potential risk factor identified in step 1, a multi-
variable model was constructed including the identified potential risk
factors, the age of the dog (forced variable), as well as variables associ-
ated with both the exposure of interest and the outcome with a P-value
<.20 (potential confounders). Univariable associations among the above
mentioned 11 variables were assessed using chi-square test (or Fisher
exact test when appropriate). If more than 2 potential confounders
were identified, only the 2 with the lowest P-value testing the associa-
tion with the exposure of interest were selected, to have no more than
4 variables included into each multivariable model.29 If a potential risk
factor remained significantly associated with the outcome in its multi-
variable model (P ≤ .05), it was considered as a risk factor for the out-
come. Continuous variables identified as risk factors were categorized
into 4 classes according to the quartiles or as binary variables (as previ-
ously defined). Identified risk factors were finally included into a new
Cox model; if these identified risk factors were continuous, they were
taken into account either as categorical (according to quartiles) or
binary variables. The Cox models were then compared by using the
Bayesian Information Criteria (BIC).30 The Cox model with the lowest
BIC value was selected to perform the scoring methods. The value of
the hazard ratio (HR) for each risk factor estimated from the selected
Cox model was used, as weighting factors, to calculate scores for each
dog. Scores were calculated through 2 scoring methods. For the first
scoring method, the weighting factor was the value of the HR corre-
sponding to the score was the value of the HR rounded to the first digit
after the decimal point. For the second scoring method, the weighting
factor was the value of the HR rounded to its integer value; when the
fractional part was 0.5 (for instance, 7.5), the value was rounded to the
closest higher integer (ie, 8). For each scoring method, the score was
calculated for each dog by adding the weighting factors based on their
individual profile on the identified risk factors. Receiver-operating char-
acteristic (ROC) analysis was performed to evaluate the effectiveness of
the score for distinguishing dogs that died within 30 days of admission
from those that remained alive both in the training and validation
cohorts.31,32 The areas under the curve (AUC) were calculated to quan-
tify this discriminatory power. The optimal cutoffs of the score were cal-
culated based on the Youden index.33 Different stages of Canine Acute
Pancreatitis Severity (CAPS) score establishment and validation are
presented by means of a flow diagram (Figure 1).
In this study, some biological variables (eg, calcium, coagulation
times, bicarbonate concentration) were missing. Biological variables
measured at the time of admission of the dog were chosen at the dis-
cretion of the attending clinician and may be limited owing to financial
restriction of the owner, which is independent of the subsequent
outcome. Therefore, data were considered missing at random. The
identification of the risk factors was performed on all dogs (to take into
account confounders more efficiently); the analyses regarding score
establishment and validation were performed only in dogs with non-
missing data of the identified risk factors. No imputation has been per-
formed. An association was considered as significant if P-value ≤.05.
All statistical analyses were performed using a commercially available
software (SAS version 9.3; SAS Institute Inc., Cary, North Carolina).
3 | RESULTS
3.1 | Population demographic and clinicopathological
data
A total of 233 dogs were included in this study. Among them, 49 dogs
were excluded because of duration of clinical signs >7 days and
15 dogs were excluded because a previous episode of AP was
reported. Therefore, the final study population was composed of
169 dogs including 138 dogs for the training cohort and 31 dogs for
the validation cohort.
The training cohort was composed of 72 males including 23 cas-
trated males and 66 females including 44 spayed females. Mean age of
the dogs at time of AP diagnosis was 10 years (range 1-20 years). Thirty-
seven breeds were represented including crossbreed dogs (n = 24, 17%),
Yorkshire Terrier (n = 18, 13%), Jack Russell Terrier (n = 12, 9%), Poodle
(n = 11, 8%), French Bulldog (n = 9, 7%), English Cocker Spaniels (n = 8,
6%), Brittany Spaniels (n = 5, 4%), Shih Tzu (n = 4, 3%), West Highland
Terrier, (n = 4, 3%), Boxer (n = 3, 2%), American Staffordshire (n = 3,
2%), Rottweiler (n = 3, 2%), and 25 other breeds represented with 1 or
2 dogs. Clinical signs consistent with AP reported at admission were leth-
argy (n = 122, 88%), anorexia (n = 119, 86%), vomiting (n = 115, 83%),
and abdominal pain (n = 81, 59%). One hundred twenty-five dogs (91%)
had a Spec cPL concentration >400 μg/L. Thirteen (9%) dogs presented
a Spec cPL concentration between 200 and 400 μg/L associated with
ultrasonographic signs of AP. Abdominal ultrasonography was performed
in 127 of 138 dogs (92%). Findings consistent with AP were observed in
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90 of 127 dogs (71%, distributed as follows: 61% in dogs with Spec
cPL > 400 μg/L and 10% with Spec cPL 200-400 μg/L).
The validation cohort was composed of 13 males including 3 cas-
trated males and 18 females including 13 spayed females. The mean
age was 10 years (range 1-16 years). Ten breeds were represented
with crossbreed dogs (n = 10, 32%), Labrador Retriever (n = 5, 19%),
and Yorkshire (n = 4, 13%); each of the other 7 breeds were repre-
sented by 1 or 2 dogs. Clinical signs reported at admission were leth-
argy (n = 26, 84%), vomiting (n = 25, 81%), anorexia (n = 19, 62%),
and abdominal pain (n = 18, 58%). For 27 dogs (87%), abnormal SNAP
cPL result, in association with abdominal ultrasonographic findings of
AP was used for diagnosis. Spec cPL concentration was available for
4 dogs (greater than 400 μg/L for 2 dogs; between 200 and 400 μg/L
for the other 2). Abdominal ultrasonography was performed in 30 of
31 dogs (97%) and was consistent with AP in 29 of 30 dogs (97%).
Spec cPL concentration was greater than 400 μg/L in the 2 dogs
for whom the diagnosis of AP was not supported by abdominal
ultrasonography.
Dogs assessed for eligibility
n = 233
Dogs excluded (n = 64)
•  Clinical signs > 7 days n = 49







Identification of risk factors 
of short-term death:







Dogs excluded (n = 71)
Missing data:
•  Ionized calcium n = 28
•  Coag disorders n = 26
•  Both n = 17
Evaluation of model performance:
AUC, optimal cut-off, 
sensitivity/specificity
n = 67
External validation of  
CAPS and sCAPS score
Score selection:
CAPS and sCAPS score
Dogs excluded (n = 10)
Missing data:
•  Ionized calcium n = 10
FIGURE 1 Flow diagram showing different stages of CAPS and sCAPS score establishment and validation. AUC, area under the curve; CAPS,
Canine Acute Pancreatitis Severity; Coag, coagulation; sCAPS, simplified Canine Acute Pancreatitis Severity; SIRS, systemic inflammatory
response syndrome
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3.2 | Outcome
The case fatality rate 30 days after admission (ie, short-term death)
was 33% (46/138 dogs) in the training cohort. Among them, 29 dogs
were euthanized (13 during the hospitalization period and 16 after
discharge). In the validation cohort, the case fatality rate 30 days after
admission was 35% (11/31 dogs). Among them, 7 dogs were eutha-
nized (3 during the hospitalization and 4 after discharge). For all dogs
in both cohorts, death within the 30 days after admission was related
to AP. Therefore, no dog was censored because of death unre-
lated to AP.
3.3 | Identification of risk factors for short-term
death
The 11 variables were initially tested for potential association with
short-term death. Among them, presence of SIRS at admission, coagula-
tion disorders, metabolic acidosis, increased creatinine, hyperkalemia,
ionized hypocalcemia, hyperglycemia, hypoalbuminemia, and Spec cPL
concentrations >1000 μg/L were associated with short-term death
with a P-value <.20 on univariable analyses (Table 1) and were there-
fore selected for the multivariable analysis.
The multivariable analysis identified SIRS (adjusted HR [aHR], 5.8;
95% confidence interval [CI], 2.2-15.4; P < .01), coagulation disorders
(aHR, 3.8; 95% CI, 1.5-9.7; P < .01), increased creatinine (aHR, 2.9;
95% CI, 1.3-6.5; P < .01), and ionized hypocalcemia (aHR, 4.5; 95% CI,
1.6-12.8; P < .01) as independent risk factors of short-term death
(Table 2). At this stage, plasma concentrations of creatinine and ionized
calcemia were also considered as categorical according to the quartiles.
Comparison of Cox models using the BIC value did not show superior-
ity of quartile-specific categorical considerations of these variables over
the binary considerations. Therefore, further analyses were performed
considering creatinine and ionized calcium as binary variables (see Sup-
porting Information).
In order to simplify the score, each variable defining SIRS (heart rate,
RR, body temperature, and WBC count) were evaluated separately as
categorical variables according to the quartiles. Only RR was associated
with short-term death after crude and adjusted analysis. In a Cox model
containing creatinine, ionized calcemia, and coagulation disorders, RR
was included considering the first quartile (RR < 24 mpm) as the refer-
ence category, and results showed similar HR for the 3 quartile-specific
categories. Consequently, these last 3 categories were combined and RR
was considered as a binary variable (RR < 24 mpm versus ≥24 mpm).
TABLE 1 Univariable association between variables and short-term death in dogs with acute pancreatitis in training cohort
Variable Total n/N0
Outcome at 30 days after-admission
P-value
Crude hazard
ratio (95% CI)Survivors n/N1 (%) Nonsurvivors n/N2 (%)
SIRS 72/138 38/92 (41) 34/46 (74) <.001 5.0 (2.3-10.8)
Coagulation disorders 13/97 4/63 (6) 9/34 (26) .006 2.9 (1.4-6.4)
Metabolic acidosis 32/85 12/51 (24) 20/34 (59) <.001 3.2 (1.6-6.4)
Hepatic injury 67/124 46/88 (52) 21/36 (58) .51 1.3 (0.7-2.6)
Increased creatinine 64/138 19/92 (21) 27/46 (59) <.001 3.7 (2.0-6.7)
Hyperkalemia 15/130 5/85 (6) 10/45 (22) .020 2.4 (1.0-5.7)
Ionized hypocalcemia 26/96 8/62 (13) 18/34 (53) <.001 4.7 (2.3-9.4)
Hyperglycemia 16/122 7/84 (8) 9/38 (24) .011 2.7 (1.3-5.6)
Hypoalbuminemia 62/101 41/71 (58) 21/30 (70) .048 1.9 (1.0-4.1)
Spec-cPL > 1000 μg/L 41/138 22/92 (24) 19/46 (41) .054 1.8 (1.0-3.2)
Age (years) 138/138 11.3 (range, 1-16) 9.3 (range, 2.3-20) .67 1.3 (0.7-2.4)
Abbreviations: CI, confidence interval; N, number of dogs for which the abnormality was investigated (N0 total, N1 survivor, N2 nonsurvivor); n, number of
dogs presenting the laboratory or clinical abnormality; SIRS, systemic inflammatory response syndrome
TABLE 2 Results from multivariable Cox proportional hazard models
Variables Two most pertinent variables with lower P-value (≤.2)a Adjusted hazard ratio (95% CI) P-value
SIRS Increased creatinine Ionized hypocalcemia 5.8 (2.2–15.4) <.001
Coagulation disorders Spec-cPL > 1000 μg/L Ionized hypocalcemia 3.8 (1.5-9.7) .005
Metabolic acidosis Ionized hypocalcemia Increased creatinine 1.5 (0.5-4.4) .44
Increased creatinine SIRS Metabolic acidosis 2.9 (1.3–6.5) .008
Hyperkalemia Increased creatinine / 1.6 (0.7-4.0) .29
Ionized hypocalcemia Hypo-albuminemia Hyperglycemia 4.5 (1.6–12.8) .005
Hyperglycemia Ionized hypocalcemia / 1.2 (0.4-4.0) .73
Hypo-albuminemia Ionized hypocalcemia Coagulation disorders 2.0 (0.8-5.0) .16
Spec-cPL > 1000 μg/L Coagulation disorders Ionized hypocalcemia 1.8 (0.8-4.2) .17
Variables significantly associated with the short-term death in dogs with acute pancreatitis (P ≤ .05) are considered as risk factors of short-term death in
the training cohort.
Abbreviations: CI, confidence interval; SIRS, systemic inflammatory response syndrome; Spec-cPL, specific canine pancreatic lipase.
aIn the multivariable model, only age (forced variable) and the 2 variables associated with the variable of interest with the lowest P-value among variable
with P ≤ .2 in the univariable analysis (considered as most pertinent confounding variable) were included as potential confounders.
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3.4 | Scoring system development
Identified risk factors in the previous analyses were simultaneously
included into a single multivariable Cox proportional hazard model to
determine weighting factors of the score for each of the 4 variables.
Model A represented the Cox model including creatinine, ionized cal-
cium, coagulation disorders, and SIRS. Model B represented the Cox
model including creatinine, ionized calcium, coagulation disorders, and
RR. BIC value of Model A and Model B was 184.1 and 176.0, respec-
tively, suggesting superiority of Model B over Model A. Consequently,
both models were kept into consideration for further analysis.
Then 4 scores were calculated: score Ad, score Ai, score Bd, and
score Bi, respectively, for scores from Model A with weighting factors
rounded after the decimal point (“d” for “decimal”), from Model A with
weighting factors rounded to the closest integer (“i” for “integer”),
from Model B with weighting factors rounded after the decimal point
and from Model B with weighting factors rounded to the closest inte-
ger (Table 3). All the 4 scores Ad, Ai, Bd, and Bi presented the same
AUC of 0.92 and the same 95% CI (0.85-0.99; Figure 2). Cutoff values,
corresponding sensitivities and specificities, and Youden index were
determined for each score and are presented in Table 4. The optimal
cutoff value of scores Ad, Ai, Bd, and Bi yielded sensitivity/specificity
of 89%/90%, 89%/90%, 96%/77%, and 96%/77%, respectively.
Considering the similar performance of the 2 scoring methods (same
Youden indexes), Scores Ai and Bi were selected to facilitate score calcu-
lation using integer values for weighting factors. Score Ai was renamed
as the “Canine Acute Pancreatic Severity (CAPS) score” and score Bi was
renamed as the “simplified Canine Acute Pancreatic Severity (sCAPS)
score”. Formula of CAPS score was 8 × (1 if SIRS, 0 otherwise) + 3 ×
(1 if coagulation disorders, 0 otherwise) + 4 × (1 if increased creatinine,
0 otherwise) + 3 × (1 if ionized hypocalcemia, 0 otherwise). Formula of
sCAPS score was 3 × (1 if RR ≥ 24 mpm, 0 otherwise) + 3 × (1 if coagu-
lation disorders, 0 otherwise) + 4 × (1 if increased creatinine, 0 other-
wise) + 3 × (1 if ionized hypocalcemia, 0 otherwise).
3.5 | Validation of the scoring system
CAPS and sCAPS scores were validated in 21 of the 31 dogs of the vali-
dation cohort for which all data for score calculation were available.
The AUC of the ROC curve for CAPS and sCAPS scores were 0.91
(95% CI, 0.77-1.00) and 0.96 (95% CI, 0.88-1.00), respectively (Table 5).
Application of the CAPS and sCAPS scores and their respective cut-
off values in the validation cohort provided sensitivity/specificity of
86%/92% and 100%/85%, respectively (Table 5), and correctly clas-
sified short-term outcome in 89% and 92% of dogs, respectively.
4 | DISCUSSION
In this study, we identified 4 independent risk factors for short-term
death in dogs with AP: presence of SIRS, coagulation disorders,
increased creatinine, and ionized hypocalcemia. We also proposed
2 scoring systems able to predict short-term death in dogs with AP:
CAPS score, developed using the 4 risk factors identified, and a simpli-
fied severity score (sCAPS score), determined for a faster calculation.
TABLE 3 Variables and corresponding weighting factors for scores Ad, Ai, Bd, and Bi
Weighting factorsa
Variables Score Ad Score Ai Score Bd Score Bi
Creatinine (mg/dL) ≥1.6 4.0 4 3.9 4
<1.6 0 0 0 0
Ionized calcium (mg/dL) <4.4 3.2 3 2.7 3
≥4.4 0 0 0 0
Coagulation disorder Yes 2.5 3 3.1 3
No 0 0 0 0
SIRS Yes 7.5 8
/ /
No 0 0




Abbreviation: SIRS, systemic inflammatory response syndrome.
aWeighting factors was assigned based on calculated hazard ratio rounded after the decimal point for scores Ad and Bd (“d” for “decimal”) or rounded to
the closest integer value for scores Ai and Bi (“i” for “integer”).
FIGURE 2 Receiver operator characteristic (ROC) curve for
prediction of short-term death in the training cohort for scores Ad, Ai,
Bd, and Bi. Each score has an area under the curve (AUC) of 0.92
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Both of them permitted accurate identification of dogs at risk of
short-term death to initiate appropriate management and monitoring
of severe form of AP. These severity scores fulfill the criteria of a
good scoring system which should be applicable at the time of diagno-
sis, easy to use, and accurate.34 CAPS and sCAPS scores allow specific
evaluation of AP severity, whereas recently developed illness severity
score such as APPLE score is intended for dogs admitted in an inten-
sive care unit regardless of the underlying disease.35,36
These scoring systems were developed in a large cohort of dogs
diagnosed with AP. Demographic data and clinical presentations in
the study population were in accordance to previously published
data.1,10,12,23 In this study, short-term death rates (33% for training
cohort and 35% for validation cohort) are similar to death rates previ-
ously reported for AP in dogs (27%-58%).20,21 In the training cohort,
abdominal ultrasonography revealed findings suggestive of AP in 70%
of the cases. This result is consistent with the previously reported sen-
sitivity (68%) of abdominal ultrasonography for diagnosis of AP in
dogs.11 In the other cases, the abdominal ultrasound findings were
not suggestive of AP but allowed exclusion of other diseases.
The CAPS score is based on 4 prognostic factors selected after
multivariable statistical analysis: presence of SIRS at admission, coagu-
lation disorders, increased creatinine concentration, and ionized hypo-
calcemia. These variables are usually recorded within the first 24 hours
of hospitalization, allowing an early evaluation of the patient risk for
short-term death. Moreover, CAPS score proposed good performance
with AUC of the ROC curve of 0.92 and 0.91 in the training and the
validation cohort, respectively.
Although presence of SIRS had already been described as a nega-
tive prognostic factor in critical dogs, this study reveals that SIRS is sta-
tistically associated with short-term death in dogs with AP.37 In human
AP, an association between SIRS and adverse outcome has also been
reported and SIRS is included in the BISAP severity score.6,18 Systemic
inflammatory condition could have been evaluated through C-reactive
protein (CRP) measurement especially because CRP has been associ-
ated with outcome prediction in dogs with AP.23,25,38 Unfortunately,
because of the retrospective design of this study and the time frame
during which the dogs were included, few dogs had CRP measured to
consider this variables in those selected.
As in previous studies, our study identified that increased coagu-
lation times or thrombocytopenia are associated with poor prognosis
in dogs with AP.25,39 These findings are consistent with a consumptive
coagulopathy, a well-recognized complication of AP in dogs.3,40
Identification of increased creatinine as a prognostic factor in
dogs with AP is in agreement with previous published studies in veter-
inary literature as well as in human literature.12,41–43 Acute kidney
injury is a complication described in dogs with AP.1 In humans, it is a
well-described complication of AP.42–44 Although the exact mecha-
nism of acute kidney injury associated with AP remains unclear,
chronic kidney disease has been associated with a higher risk of death
in humans diagnosed with AP.42,44
Finally, ionized hypocalcemia was identified as a risk factor for short-
term death in this study. Hypocalcemia has already been associated with
poor outcome in humans and cats with AP but not yet in dogs.45–47
However, ionized calcium measurement and coagulation profile are
not always available in all clinical practices, making it less accessible at
admission time for all veterinarians. Moreover, evaluation of SIRS may
be time consuming, considering the fact that it requires evaluation of
4 systems. Therefore, a simplified score including RR instead of SIRS
was proposed. The sCAPS score presents good performance character-
istics with AUC of the ROC curve of 0.92 and 0.96 in the training and
the validation cohort, respectively, and allows faster calculation. More-
over, its good sensitivity (96%) allows accurate identification of dogs
necessitating intensive care. However, the user must be aware of its
lower specificity (77%) when compared to CAPS score specificity of
90%. This finding may be explained by the lack of specificity of an
increased RR, which can occur secondary to nondisease conditions such
as stress. Considering this limit, sCAPS score should never be used for
prognostic evaluation, for which the use of CAPS score seems more
appropriate due to a higher specificity. Consequently, CAPS score
remains recommended to optimize predictive accuracy.
Limitations of this study include the lack of ultrasonography in
11 dogs (6.5%) for which Spec cPL concentration was above 400 μg/L.
TABLE 4 Performance characteristics for short-term death prediction of scores Ad, Ai, Bd and Bi on training cohort
Score Optimal cutoff Sensitivity (%) Specificity (%) Youden index AUC 95% CI for AUC
Ad 10.0 89 90 0.79 0.92 0.85-0.99
Ai 11 89 90 0.79 0.92 0.85-0.99
Bd 5.4 96 77 0.73 0.92 0.85-0.99
Bi 6 96 77 0.73 0.92 0.85-0.99
Score Ad, from model A with weighting factors rounded after the decimal point.
Score Ai, from model A with weighting factors rounded to the closest integer.
Score Bd, from model B with weighting factors rounded after the decimal point.
Score Bi from model B with weighting factors rounded to the closest integer.
Abbreviations: AUC, area under the ROC curve; CI, Confidence Interval.
TABLE 5 Performance characteristics for short-term death prediction of CAPS and sCAPS scores on validation cohort
Model Optimal cutoff Sensitivity (%) Specificity (%) Youden index Correctly classified (%) AUC 95% CI for AUC
CAPS score 11 86 92 0.79 89 0.91 0.77-1.00
sCAPS score 6 100 85 0.73 92 0.96 0.88-1.00
CAPS score corresponding to score Ai; sCAPS score corresponding to Score Bi.
Abbreviations: AUC, area under the ROC curve; CAPS, Canine Acute Pancreatitis Severity; CI, confidence interval; sCAPS, simplified Canine Acute Pancre-
atitis Severity.
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For these dogs, misdiagnosis could not be excluded, as up to 23% of
dogs with acute abdominal disease not related to AP might present
Spec cPL results consistent with AP.48
Secondly, the retrospective design of the study explains the lack of
data for several dogs. Therefore, variables associated with death were
possibly falsely excluded because of insufficient statistical power (eg,
metabolic acidosis). Also, some risk factors were not tested and could
have proven useful in the score determination. For example, cardiovas-
cular injury was not assessed because relevant data necessary to deter-
mine this variable were lacking in many cases. Likewise, concomitant
diseases such as hyperadrenocorticism or hypothyroidism have not
been investigated as a potential risk factor for death because this infor-
mation was not always available at the time of admission or investi-
gated during AP management. In the training cohort, only 9 dogs were
known to have a concomitant disease at the time of diagnosis. We did
not include this variable in the univariable analysis as the proportion of
dogs affected was probably underestimated.
Thirdly, outcome defined as death within 30 days after admission
included naturally dead and euthanized dogs. In veterinary medicine,
the prevalence of euthanasia poses a unique challenge to all scores
based on death outcome. Inclusion of euthanized dogs represents a
bias as clinician perception of clinical signs or clinicopathological data
during the follow-up of the dog probably influence the owner's deci-
sion of euthanasia. Although we excluded dogs euthanized for reasons
unrelated to AP, we cannot exclude that false-positive death associa-
tion occurred. In the same way, misclassification errors on the event
(ie, wrongly considering as a death secondary to AP) may have
occurred. Such errors lead to misclassification bias, which reduces the
strength of the association between the exposure and the outcome.
We therefore might have not identified risk factors for death from AP,
because they were not significantly associated with the study out-
come. However, if any, these errors should be few considering that
details of the death were available for most of the dogs.
Finally, a 30-day period after admission was chosen for the evalua-
tion of outcome drawing on previous study dealing with survival in
acute diseases.28,49–51 By considering the 30-day outcome, we wanted
to identify dogs at risk of short-term death requiring early and appropri-
ate management. We cannot exclude that some dogs died few days
after the 30-day period. Therefore, our results cannot be generalized to
middle (ie, >30 days after admission) or long-term death due to AP.
Considering these limitations, the quality of this scoring system
can certainly be improved by a prospective validation. Furthermore, it
would be interesting to prospectively assess the evolution of variables
over time. In human medicine, assessment of variables at admission
and within the first 48 hours post-admission are used for outcome
prediction of AP.15,18 In veterinary medicine, serial CRP concentration
measurements were also proven as potential prognostic risk factor in
AP.25 The retrospective nature of our study did not allow us to assess
the change of laboratory variables as outcome predictors; we thus
suggest this investigation in a future, prospective study.
Finally, CAPS and sCAPS scores might prove useful to demon-
strate effective randomization of dogs in clinical trial. One of its
objectives is to guide appropriate management of severe AP and its
usefulness should be confirmed in a study evaluating different thera-
peutic strategies.
In conclusion, this study proposes 2 scoring systems applicable
early after admission to help clinicians identifying dogs with AP at high-
risk of short-term death and thus undertake appropriate management.
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